C hina is a hyperendemic area of hepatitis B virus (HBV) infection with an estimated more than 300,000 HBV infection-related deaths each year. 1, 2 Although routine infant vaccination has been implemented since 1992, the national HBV prevalence rate for the general population was still as high as 7.2% in 2006. 3 Paid plasma and blood collection by unlicensed operations was rampant during the 1980s for high profits. Plasma was centrifuged from pooled whole blood donations from numbers of paid donors and the pooled red blood cells with the same blood type were then divided and retransfused back to the donors, which undoubtedly contributed to the rapid spread of transfusion-transmitted infectious diseases in China. 4 Through the implementation of the Blood Donation Law in 1998, the Chinese government banned paid blood donations for clinical use and encouraged 100% usage of voluntary blood donations. Consequently, after elimination of paid donors, married status, dental treatment, and high-risk sexual behavior were reported as the risk factors associated with transfusion-transmitted HBV. 5 Before 2012, routine blood screening included two rounds of postdonation hepatitis B surface antigen (HBsAg) enzyme-linked immunosorbent assay (ELISA) testing with some blood centers also performing predonation HBsAg rapid testing. In 2012, the Chinese Ministry of Health issued a modified testing requirement, which allows blood centers to screen for HBV in two alternative ways: 1) two rounds of HBsAg ELISA using kits from different manufacturers or 2) one round of HBsAg ELISA and one round of nucleic acid testing (NAT) for HBV DNA. NAT is usually used to detect the viral nucleic acid among donors, which can shorten the window period and specifically detect the occult HBV infections (OBIs) to reduce the HBV transfusion residual risks. OBI is defined as the long-lasting persistence of HBV genomes in the liver tissue with detectable or undetectable HBV DNA in the serum from HBsAg-negative individuals. 6 OBI may persist in the host for years without obvious symptoms of HBV infection 7 or it may develop into hepatitis or cirrhosis. 8 OBI donors are frequently detected during blood donor screening. 9, 10 In practice, many blood centers also conduct predonation rapid HBsAg testing as well as rapid alanine aminotransferase testing to increase costeffectiveness. Only donors who passed the predonation rapid testing would proceed to giving blood. With all these efforts, transfusion-transmitted HBV risk has been reduced compared to the past. However, China remains a HBV hyperepidemic country, and HBV infection through transfusion remains a significant challenge for blood safety in China. Dozens of studies aimed at examining HBV epidemiology and risk factors among blood donors have been carried out in China. However, the results from some studies were conflicting. There was a lack of nationally representative samples. Many studies did not have sufficient sample size or did not use valid statistical methods. There is a warranted need to examine HBV epidemiology in China in a systematic manner. Currently, there is no nationwide surveillance of HBV among Chinese blood donors. Therefore, meta-analysis, a statistical method that can combine findings from numerous independent studies on HBV infection among blood donors in multiple regions in the country, is chosen as a reasonable way to address this issue. By using meta-analysis, this study has investigated the HBV blood screening reactive rate and illustrated the demographics of the corresponding blood donors with revealing of heterogeneity between previous studies during the past 30 years in mainland China.
MATERIALS AND METHODS

Literature selection and data extraction
The inclusion criteria included: 1) the study was conducted only in mainland China (Hong Kong, Taiwan, and Macao were excluded); 2) the screening test for HBsAg should use ELISA and NAT and screening strategy should follow the government required standardized donor screening policies; and 3) studies involved HBsAg ELISA reactivity and HBV NAT positivity. The exclusion criteria were as follows: 1) studies without exact sample size; 2) sample size less than 50; 3) overlapping or paradoxical studies: data from literature were repeat or inconsistent between the context; and 4) plasma donors for manufacturers. In addition, literature with missing study year was categorized as "before 1998" or "after 1998" according to the publication date of the journal to minimize the further publication bias. All the relevant literatures were reviewed independently by two experienced investigators, and any discrepancies were resolved by consulting a third author, Dr He, to achieve consensus.
Literature search
We attempted to follow the proposed PRISMA guidelines to plan, conduct, and report this meta-analysis. The electronic literature search on HBV epidemiology among blood donors in mainland China was conducted using China National Knowledge Infrastructure, Medline, PubMed, and Wanfang Data (a Chinese professional academic database developed by Wanfang data limitedliability company) from 1979 to 2014 using the key words "HBV" or "hepatitis B virus"; "blood"; "blood donors"; "blood centers"; or "donation"; "transfusion transmitted disease"; "screening reactive" or "disqualification"; "epidemiology"; and "China" or "Mainland China." No language restrictions were applied.
HBV screening strategies
Postdonation was defined as collecting a donation when the predonation is qualified and then the sample will be tested with two methods before the unit (if negative) is released and transfused. The postdonation testing concept is similar to the blood screening test in Western counties. The rate of HBV reactive was defined as HBsAg predonation rapid testing reactive or HBsAg postdonation screening testing reactive. Reverse passive hemagglutination assay was used to perform HBV predonation rapid test in some studies before 1998, while immune colloidal gold technique was more frequently used after 1998. However, whether predonation rapid test was performed or not, each donation must go through two rounds of ELISA using kits from different manufacturers. Samples with equivocal results (reactive in one of two rounds) will be retested in double well. Then only double-well retested nonreactive donations will be qualified for clinical use. Most blood centers do not routinely perform confirmatory testing for HBsAg screening reactive samples.
Quality assessment of the studies
Considering this cross-sectional study, combined with the applicability of the quality assessment, all included studies were assessed for methodologic quality using the prevalence critical appraisal instrument developed by Munn and colleagues. 11 
Statistical analysis
Pooled results for HBsAg screening reactive rate and corresponding 95% confidence intervals (CIs) were used to assess the blood safety status among blood centers in China. The heterogeneity between studies was tested by the Q test and I 2 statistical test. In our study, DerSimonian-Laird random-effects model was used to calculate the pooled odds ratios considering the high heterogeneity of the collected studies (I 2 > 90%, p < 0.1).
Meta-regression analysis based on multiple factors (publication year, province, sex ratio, sample size, ELISA kit) was performed to find the source of heterogeneity. In addition, publication bias was assessed by Egger's tests, in which p < 0.05 represents significance. Stratified analyses based on characteristics were performed and the Z or chi-square test was used to assess the statistical difference among subgroups. All data analyses were performed with computer software (Stata Statistical Software Package 12.0, StataCorp) for the statistical analysis. The PRISMA flow diagram and geographical distribution maps were made by Adobe Photoshop 12.0 (http:// www.adobe.com/), and the trend plot was made by Joinpoint Regression Program (https://surveillance.cancer. gov/help/joinpoint).
RESULTS
Process of studies selection
Based on the inclusion and exclusion criteria ( Demographic characteristics were categorized as sex, age, ethnicity, occupation, education level, and blood type. Additional information was extracted, including author, publication date, study year, name of the journal, study site (province), sample size, number of subjects infected with HBV, and donation motivation.
There are four types of voluntary donations in Mainland China: 1) Individual-They donate blood voluntarily without compensation, coercion, or instigation. 2) GroupThey donate blood as organized units usually with an appointment made between units and centers. They mostly come from large organizations which may offer some compensation for donors. 3) Planned-The planned voluntary donors were requested by their employer to donate blood for meeting the planned donation quota assigned by the local governments. Some planned voluntary donors may receive monetary incentives or time off work. 12,13 4) Family or replacement-Due to shortage of blood supply, family members or relatives of a patient who needs blood transfusion were asked by the hospital to donate blood for replacement of the volume of donation transfused to the patient.
General information
A total of 64,252,305 individual voluntary blood donors were included in final analyses. Donor demographic and donation information were tabulated, as presented in Table 1 . All the 31 provinces, autonomous regions and municipalities in mainland China were included as follow: East China, North China, South China, Central China, Northwest China, Southwest China, and Northeast China.
HBsAg screening reactive rate
The screening reactive rate is defined as HBsAg postdonation ELISA screening reactive donations out of all tested samples, and the pooled statistical result of HBsAg screening reactive rate is presented in Table 2 . The overall pooled screening reactive rate among voluntary blood donors in mainland China was 1.32% (95% CI, 1.28%-1.36%), ranging from 0.45% to 2.45% in different regions. The overall screening reactive rate before 1998 was 3.93% (95% CI, 3.45%-4.40%). The overall screening reactive rate after 1998 was 1.22% (95% CI, 1.18%-1.27%). Dramatic regional difference in screening reactive rate among blood donors was observed, among which South China (1.68%; 95% CI, 1.52%-1.83%) and East China (1.60%; 95% CI, 1.52%-1.68%) had a relatively high screening reactive rate, while the lowest screening reactive rate was found in Northeast China of 0.81% (95% CI, 0.67%-0.95%). Figures 2 and 3 show geographical distribution of HBV screening reactive rates before and after 1998. The overall screening reactive rate decreased over the years, as presented in Fig. 4 . In addition, the pooled results for predonation rapid test of HBsAg was 6.08% (95% CI, 3.68%-8.48%). 
Demographics of HBsAg screening reactive donors
Ethnicity
We also investigated the association between HBsAg screening reactive results and ethnicity. The results showed that Tibetans had the highest screening reactive rate (2.73%; 95% CI, 0.9%-4.50%), followed by Han (2.36%; 95% CI, 0.51%-4.20%) and Hui (0.92%; 95% CI, 0.53%-1.32%). There was a significant statistical difference in HBV screening reactive rate between Tibetian and Hui (z 5 3.27, p 5 0.001); however, no difference was found between the rest of the groups (p > 0.05).
Blood group
The HBsAg screening reactive rates among blood group A, B, AB, and O blood donors were pooled and investigated. Group A had the highest screening reactive rate (1.93%; 95% CI, 1.34%-2.52%), and group O group had the lowest screening reactive rate (1.68%; 95% CI, 1.17%-2.19%). No significant differences were observed among the four blood groups.
Occupation
A total of 52 studies were pooled and subjects were divided into four groups according to the occupation. Farmers had the highest screening reactive rate (2.14%; 95% CI, 1.77%-2.51%), while the lowest (0.59%; 95% CI, 0.45%-0.73%) were military soldiers. Employees and students had similar screening reactive rates of 1.69 and 1.66%. Significant differences (p < 0.05) were observed between military soldiers and other groups and between farmers and students. No significant difference was found between farmers and the employees (z 5 1.87, p 5 0.062).
Education
Donors who received lower than high school education had the highest HBsAg screening reactive rate (1.10%, 95% CI 0.88%-1.32%) compared to the donors with higher education levels (high school-0.77%, 95% CI 0.63-0.91%; junior college-0.78%, 95% CI 0.63-0.94%; bachelor's degree or above-0.79%, 95% CI 0.61%-0.97%). There was a significant difference (p < 0.05) between lower than high school and the other three groups, while no difference was found among the groups who received education higher than high school. reactive rate for first-time donors was 1.77% (95% CI, 1.55%-1.99%) and 0.23% (95% CI, 0.19%-0.27%) for repeat donors. A significant difference between them was found (p < 0.05).
Donation motivation and donation frequency
NAT
There were 25 studies indicating the association between the HBV screening reactive rate and NAT result. Overall pooled NAT blood screening reactive rate for HBV DNA was 0.11% (95% CI, 0.09%-0.13%).
Year
The overall HBsAg screening reactive rate showed a decreasing trend since 1998. As presented in Fig. 4 , the joinpoint trend for HBV screening reactive decreased significantly, by 216.8% (95% CI, 233.6 to 4. sample size, and ELISA kit) showed that the variable included in the regression was the publication year (p < 0.05), which may explain part of heterogeneity (Table S1 , available as supporting information in the online version of this paper)
Publication bias
The publication bias was assessed by Egger's test, and the results showed significant publication bias (p < 0.05). Meanwhile, we had performed the further bias analysis based on various subgroups: In geographic locations, publication bias (p < 0.05) was found in 16 provinces; in age group, publication bias was found in the age of 18 to 25; in education group, publication bias was found in junior college and high school; in donation type, publication bias was found in planned and individual donation; and in the groups of sex, blood group, occupation, donation frequency, and sample size, significant publication bias (p < 0.05) was found. No significant publication bias (p > 0.05) was found in the rest of groups or subgroups (Table S2 , available as supporting information in the online version of this paper).
DISCUSSION
More than 2 billion people in the world have been infected with HBV and more than 378 million persons are chronic carriers. Approximately 600,000 people die from HBV-associated liver disease each year. [14] [15] [16] In mainland China, the blood supply mostly relied on paid and Table 2) . A previous report has suggested that the lack of effective prevention strategies might have contributed to this higher rate in Qinghai. 17 However, further research on the HBV high prevalence and associated risk factors needs to be performed in Qinghai. A previous study has suggested that people from rural areas might have a higher prevalence rate of HBV because of lower hepatitis B vaccination. 3, 18 This situation is similar to some other developing countries where continuing HBV outbreaks in rural areas often happen, which might be ascribed to poor public health awareness and poor infection control activities. [19] [20] [21] [22] [23] Another important reason is that a large number of migrant workers in rural-urban areas are often separated from their spouses or sexual partners for long periods of time. These migrant workers usually have limited entertainment after work and their experience with lowpaid sex workers with high-risk sexual behaviors greatly increased the risk of HBV infection. Interestingly, the HBsAg screening reactive rate of planned voluntary blood donors was nearly 1.3 times that of the individual voluntary donors. However, according to a recent report, although the planned voluntary donors still constitute a necessary part for adequate blood supply in some big cities in China, there were only less than 1% of planned voluntary donors left nationwide in 2012. 24 More importantly, the HBsAg screening reactive rate among family or replacement voluntary blood donors showed a significant difference compared to the individual voluntary blood donors, which was consistent with some previous reports. 6, 7, 25 The reason might be that family or replacement voluntary donors were family members or relatives to the patient who needed transfusion and these donors often are not entirely voluntary or well informed when they donate blood. In some cases, paid donors led by some illegal profit-oriented organization may pose as family or replacement voluntary donors and these donors may carry higher risks due to high-risk behaviors. The chronic and sometimes severe blood shortage in some large cities has created the need for the family or replacement donations and reopened a door for blood dealers and paid donors to enter the donor pool as family or replacement voluntary donors. This is a new challenge that Chinese government and blood centers need to address to safeguard blood safety.
Since the "National Nucleic Acid Testing Project" was launched in 2010, NAT has been gradually implemented in blood centers. [26] [27] [28] In our meta-analyses, 0.11% NATreactive HBV-infected donors suggests the potential residual transfusion-transmissible HBV risk and it indicates the importance of nationwide implementation of NAT to prevent transfusion-transmitted HBV infection. By NAT, we can trace positive donors to confirm the OBI rate in donors and further help provide plausible prevention and control measures. In summary, planned and family or replacement voluntary blood donors should be regarded as higher-risk groups. Donations from these groups should be minimized to reduce the risk of potential HBV transfusion transmission. Other comprehensive efforts to lower the HBV risk may include: 1) designing a first-time donor's follow-up mechanism to encourage more first-time donors to be converted into repeat donations; 2) building linked deferred donor registries that will help to defer donors who previously were identified as HBV reactive at different locations; 3) continuing the nationwide implementation of NAT in donor routine screening to detect HBV window period infections and OBIs; and 4) educating donors on the awareness of HBV prevention, such as routine vaccination for infants and safe sexual behaviors. These will all be of tremendous importance to safeguard Chinese blood safety.
In general, heterogeneity could not be avoided in the meta-analyses, especially those based on cross-sectional combined with the widespread and longtime period studies. 29 With significant heterogeneity in our study, we used random-effects models to partly eliminate the influence of heterogeneity. Additionally, we further analyzed the potential sources of heterogeneity by subgroup with meta-regression method, and the results showed that publication year may contribute more heterogeneity than other groups. All literature included in our study was strictly screened and was eligible for the meta-analysis. Publication bias was determined to be present in various subgroups of this study. It is worth noting that before 1998, some provinces had fewer than three published reports, which may weaken the power of the meta-analysis. However, some related literature had to be excluded due to the low quality and less details. In addition, only studies published in Chinese and English were included in our study, which may relatively have a substantial role in the publication bias. Even so, a comprehensive search strategy combined with the large sample size and multiple resources in this study may have helped to minimize publication bias.
The meta-analysis results presented here are subject to some limitations: 1) All studies used crosssectional observational study design. 2) Most of the literature included in this study was restricted to Chinese language and very few in English.
3) The reagents used for HBsAg screening test were from different manufacturers or different generations, and ELISA reactive criteria slightly varied between blood centers. 4) There is a lack of confirmatory testing for HBsAg reactive donations to illustrate the prevalence of HBV infection. 5) Some confusing data from low quality literature could not be confirmed and had to be excluded for lack of reaching the authors.
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